A risk-stratified therapy for infants with acute lymphoblastic leukemia: a report from the JPLSG MLL-10 trialDaisuke Tomizawa, Katsuyoshi Koh, Takako Miyamura et al.|Blood|2020Cited by 102
Long-term outcome of 6-month maintenance chemotherapy for acute lymphoblastic leukemia in childrenMotohiro Kato, Atsushi Manabe, S Ishimaru et al.|Leukemia|2016Cited by 62
Multi-omics analysis defines highly refractory RAS burdened immature subgroup of infant acute lymphoblastic leukemiaTomoya Isobe, Berthold Göttgens, Akiho Tsuchiya et al.|Nature Communications|2022Cited by 36
Genomic analysis of clonal origin of Langerhans cell histiocytosis following acute lymphoblastic leukaemiaMotohiro Kato, Junko Takita, Masafumi Seki et al.|British Journal of Haematology|2015Cited by 15
Nationwide survey of pediatric hypodiploid acute lymphoblastic leukemia in JapanS Ishimaru, Katsuyoshi Koh, Yasuhiro Okamoto et al.|Pediatrics International|2019Cited by 2